Schaeffer's Top Stock Picks for '25

Drug Stock Sinks Lower on FDA Delay

Short interest has surged on ZGNX

Managing Editor
Feb 27, 2020 at 1:48 PM
facebook X logo linkedin


Pharmaceutical name Zogenix, Inc. (NASDAQ:ZGNX) is sinking lower this afternoon, suffering a notable 6.5% setback after the Food and Drug Administration (FDA) delayed the company's seizure drug application. The new target date for its Dravet syndrome drug, Fintepla, has now been pushed to June 25.

Now trading just below $24, ZGNX earlier plunged to a more than two-year low of $18.27. The equity is eyeing its fifth-straight close in the red and third notable bear gap this month. Longer-term, Zogenix stock has a steep 53% year-over-year deficit.  

Daily ZGNX Since Feb 2019

Short interest on ZGNX has soared 16.3% during the most recent reporting period, and now accounts for nearly 17% of the stock's total available float. With 7.13 million shares sold short, it would take nearly two weeks for short to buy back their bearish bets at the equity's average pace of trading.

Lastly, its worth nothing the drug stock's Schaeffer's put/call open interest ratio (SOIR) of 0.31, which sits in just the 17th percentile of its annual range. This suggests short-term option players have rarely been more call heavy in the past 12 months.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?

 

 

(function(doc, script) { var js, fjs = doc.getElementsByTagName(script)[0], frag = doc.createDocumentFragment(), add = function(url, id) { if (doc.getElementById(id)) {return;} js = doc.createElement(script); js.src = url; id && (js.id = id); frag.appendChild( js ); }; // Google+ button //add('https://apis.google.com/js/platform.js', async="defer"); // Facebook SDK add('//connect.facebook.net/en_US/all.js#xfbml=1&appId=772755279557744', 'facebook-jssdk'); // Twitter SDK //add('//platform.twitter.com/widgets.js', charset='utf-8'); fjs.parentNode.insertBefore(frag, fjs); }(document, 'script'));